Dash Bio accelerates clinical development by delivering high-quality, technology-driven bioanalysis at unprecedented speed. Its fully automated, GLP-compliant lab platform combines robotics, AI, and integrated software to deliver faster results and better data- helping biopharma teams get therapies to patients faster.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 07/23/25 | $11,000,000 |
Cybernetix Ventures Drive Capital FreeStyle Capital LifeX Ventures Swift Ventures The Aligned Fund  | undisclosed |
